Found 8 matching trials
Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
PHASE21)Preliminarily evaluate the treatment effect of Icotinib Hydrochloride Tab...
Location
Beijing Tiantan Hospital Affiliated to Capital Medical University
Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma
PHASE3The investigators performed a randomized, double blind controlled, prospect...
Location
Multiple Locations
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC
PHASE2To assess the efficacy and safety of D-0316 versus Icotinib, a standard of ...
Location
The First Affiliated Hospital of Medical School of Zhejiang University
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study
N/AThis study is a prospective, multicenter, real-world study to investigate t...
Location
Guangdong Provincial People's Hospital
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
PHASE2This single-arm pilot study tries to invesitgate how well giving icotinib w...
Location
Zhejiang University
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
NAThe Single-arm, multicenter study evaluate the safety and efficacy of Anlot...
Location
Guangdong General Hospital
Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer
NAAfter the second-line treatment of patients with non-T790M mutations, chemo...
Location
The First Affiliated hospital of soochow university
Conmana Combined With Thalidomide to Treat NSCLC
PHASE4Our study the NSCLC harbors EGFR-mutation with Conmana combined with thalid...